Baylin Technologies (TSX:BYL) Among Paradigm Capital’s Buy Favourites for Fourth Quarter 2016

Baylin Technologies (TSX:BYL) Among Paradigm Capital’s Buy Favourites for Fourth Quarter 2016

Excerpt from cantech letter: Paradigm Capital today released its top picks for the fourth quarter of 2016 and the innovation sectors figure prominently in the firm’s best ideas. Among Paradigm’s favourites are Baylin Technologies (TSX:BYL), Firan Technology Group (TSX:FTG), ProMetic Life Sciences (TSX:PLI) and Shopify (TSX:SH, Nasdaq:SHOP). Analyst Daniel Kim says the underperforming Baylin Technologies… Continue Reading

CanTech Letter: Baylin Technologies has Triple-Digit Upside says Paradigm

CanTech Letter: Baylin Technologies has Triple-Digit Upside says Paradigm

From cantech letter: Analyst Daniel Kim “It’s stock has shown renewed signs of life in 2016, but Paradigm Capital analyst Daniel Kim thinks there is still a ton of upside left in Baylin Technologies (TSX:BYL). In a research update to clients today, Kim maintained his “Buy” ourhealthissues.com/product/strattera/ rating and one-year price target of $5.00 on Baylin,… Continue Reading

Clear Signals. Sound Investments.

Baylin's investment position is based on experience, innovation, and execution — 38 years of doing it right.